Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3560
-0.0190 (-5.07%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Co-Diagnostics Employees
Co-Diagnostics had 132 employees as of December 31, 2024. The number of employees decreased by 23 or -14.84% compared to the previous year.
Employees
132
Change (1Y)
-23
Growth (1Y)
-14.84%
Revenue / Employee
$29,660
Profits / Employee
-$285,144
Market Cap
11.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
CODX News
- 27 days ago - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - PRNewsWire
- 7 weeks ago - Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PRNewsWire
- 2 months ago - Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Benzinga
- 2 months ago - Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PRNewsWire
- 4 months ago - Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - PRNewsWire